Ozempic vs Wegovy: Same Drug, Different Doses

What They Have in Common

Both Ozempic and Wegovy:

• Contain semaglutide, a GLP-1 receptor agonist
• Are manufactured by Novo Nordisk
• Are weekly subcutaneous injections
• Use similar titration schedules (slower escalation = better tolerance)
• Have the same mechanism: suppress appetite, slow gastric emptying, improve insulin regulation

If you're reading studies about "semaglutide for weight loss," they apply to both — the drug is the same.

The Differences That Actually Matter

Why the Dose Difference Matters

The dose difference between Ozempic (max 2 mg) and Wegovy (max 2.4 mg) produces meaningfully different weight loss outcomes. The STEP 1 trial showed:

• 1 mg semaglutide: ~8% body weight loss
• 2.4 mg semaglutide (Wegovy dose): ~14.9% body weight loss

The additional 0.4 mg in Wegovy's maximum dose accounts for a substantial portion of the weight loss difference. If you're prescribed Ozempic off-label for weight loss and capped at 2 mg, you're leaving some efficacy on the table compared to Wegovy.

The Off-Label Reality

Because Ozempic is less expensive and has been on the market longer, some providers prescribe it off-label for weight loss in patients without diabetes. This:

• Is legal (providers can prescribe off-label)
• May have lower insurance coverage rates (indication mismatch)
• Limits you to the 2 mg maximum dose
• Doesn't qualify for the full Wegovy savings card benefits in all situations

If your goal is weight loss and you don't have type 2 diabetes, the correct on-label prescription is Wegovy.

Insurance Coverage: Why This Distinction Matters

Insurance plans follow FDA indications when making coverage decisions:

Ozempic: Covered when prescribed for type 2 diabetes. Most plans require documentation of a diabetes diagnosis. If prescribed for weight loss without diabetes, many plans will deny it.

Wegovy: Covered when prescribed for obesity (BMI ≥30 or ≥27 with comorbidity). Requires prior authorization with BMI and comorbidity documentation. Since 2024, also covered by Medicare for patients with established cardiovascular disease.

Getting a Wegovy prescription when you have obesity (not diabetes) — and then going through proper prior authorization — is the path most likely to achieve insurance coverage.

What to Do If Ozempic Is Prescribed Instead of Wegovy

Some providers default to Ozempic because they're more familiar with it, it's been on the market since 2017, or because of formulary preferences. If you're prescribed Ozempic for weight loss:

1. Ask if Wegovy is available on your insurance formulary
2. If Wegovy is on your formulary, request a Wegovy prescription instead
3. If cost is the concern, apply for the Novo Nordisk savings card for both (both offer ~$25/month for eligible commercially insured patients)
4. If your insurance won't cover Wegovy, the savings card often makes the out-of-pocket cost similar

When Ozempic Is the Right Choice

Ozempic is appropriate — and the better prescription — when:

• You have type 2 diabetes as the primary indication
• Your insurance has better coverage for Ozempic than Wegovy
• You're managing blood sugar as the primary goal, with weight loss secondary
• You've already been titrated on Ozempic and are stable

Bottom Line

Ozempic and Wegovy contain the same drug. The differences are dose ceiling, FDA indication, and insurance coverage. For weight loss without diabetes, Wegovy is the correct prescription. For type 2 diabetes management (with weight loss as a secondary benefit), Ozempic is the on-label choice. Don't pay more for Wegovy if Ozempic is appropriately prescribed for your diagnosis — but don't settle for the lower dose if Wegovy is what you actually need.

Sources

• FDA, "Wegovy (semaglutide) Prescribing Information," 2023
• FDA, "Ozempic (semaglutide) Prescribing Information," 2023
• Wilding JPH et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM, 2021